| Field | Specification |
|---|---|
| Mfr No | |
| Accession Number | |
| Alternative Names | FAS, APT1, FAS1, TNFRSF6, Tumor necrosis factor receptor superfamily member 6 |
| Product Type | |
| Shipping | |
| Species | |
| Storage | |
| UniProt # |
Scientific Background
CD95 (Fas, APO-1, TNFRSF6) is a transmembrane cell-surface receptor with multifunctional regulatory effects in apoptosis and proliferation regulation. In some cellular contexts, interactions with the receptor ligand (CD95L) have been shown to activate JNK, ERK1, and NF-kB pathways to induce cell proliferation. In other cases, ligand interactions can trigger the release of a cytoplasmic death domain and induce apoptosis. This function is used by the immune system to kill cancer cells, and consequently, cancer cells can become resistant to CD95-induced apoptosis. The overexpression of CD95 in this cell line allows for the rapid testing of novel therapeutics that aim to increase CD95-mediated apoptosis in cancer cells.
Product Description
ImmunotherapyThe CD95 CHO cell line is a recombinant clonal stable CHO cell line constitutively expressing full-length human CD95 receptor (accession number: NM_000043.3). Surface expression of human CD95 was confirmed by flow cytometry. Each clonal cell line was selected for different levels of CD95 expression (High or Medium) to mimic varying CD95 expression levels in cancer cells.
Product Specifications
| Host Cell Line | CHO-K1 |
|---|---|
| Host Species | Hamster, epithelial-like cells, adherent |
| Transfection Method | Lipofectamine 2000 |
| Supplied As | Each vial contains 2 x 106 cells in 1 ml of cell freezing medium (BPS Bioscience #79796) |
| Harmonized Tariff Code | 3002-5900 |
Quality Control & Validation
✓ Mycoplasma-TestedThe cell line has been screened to confirm the absence of Mycoplasma species.
Safety & Handling
⚠ Avoid freeze/thaw cycles.
Regulatory Information
License Disclosure
Related Products
Related Products: Cat. #101141, 71265, 71280
Required Accessories: Cat. #60186,79529,79796
This product is engineered on a CHO-K1 background (Human origin). The CHO-K1 host was selected for its compatibility with stable transfection and the target pathway or assay type. Consult the product datasheet for passage number guidance and recommended culture media.
This product is classified as BSL-1. Standard microbiological practices (gloves, lab coat, eye protection) are sufficient. No specialized containment facility is required beyond a clean bench. Consult your institutional IBC for GMO registration requirements.
Yes. The cell line has been screened to confirm the absence of Mycoplasma species. We recommend that you independently confirm mycoplasma-negative status after receipt and periodically during routine culture using a validated detection kit.
Store this product at Liquid Nitrogen. Specifically: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage. Transfer cells from dry-ice shipping to the recommended storage immediately upon receipt. Avoid repeated freeze-thaw cycles, which reduce viability and may alter expression characteristics.
Yes, a license is required (Yes). Purchase of this cell line grants a time-limited research-use license for use in your immediate laboratory only. This license does not permit redistribution, sub-licensing, transfer to other institutions, or commercial use. Refer to the License Disclosure section on this page or contact BPS Bioscience for details regarding modifications or commercial licensing.
This stable cell line was generated using Lipofectamine 2000 for transgene delivery into the parental host. The stably integrated cells were selected using the appropriate resistance marker and verified for expression prior to cryopreservation.
Can't find the cell line you need—or require a custom engineered model for your study? We offer end-to-end support for diverse research needs, including:
- Cell line sourcing and selection (species, tissue, and disease model matching)
- Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA)
- Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs)
- Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles)
- Inducible expression systems (Tet-On/Off and regulatable constructs)
- Drug resistance marker selection (puromycin, G418, hygromycin, and others)
- Custom growth and media optimisation for specific assay requirements
- Scale-up production for high-throughput screening campaigns
- Authentication and QC services (STR profiling, mycoplasma testing, viability assessment)
Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.